Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 3

Sponsor Class

OTHER 4INDUSTRY 3NETWORK 1FED 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 3Head & Neck 1

Conditions

Prostatic Neoplasms 3Salivary Gland Adenoma, Pleomorphic 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × histrelin × Clear all
NCT01013025 2024-01-02

Vantas Implant Retrieval Study

Endo Pharmaceuticals

Completed
12 enrolled
Genitourinary

Prostatic Neoplasms

NCT01394263 2024-01-02

Study of Histrelin Subdermal Implant in Patients With Prostate Cancer

Endo Pharmaceuticals

Phase 3 Completed
59 enrolled
Genitourinary

Prostatic Neoplasms

NCT01697384 2024-01-02

Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer

Endo Pharmaceuticals

Phase 3 Completed
138 enrolled
GenitourinaryHead & Neck

Salivary Gland Adenoma, Pleomorphic, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡